Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
Lifirafenib (BGB-283) CAS：1446090-79-4
Lifirafenib (BGB-283)
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1805 | 10mg | 125.00 | + Add to cart |
|
| R-C-1805 | 50mg | 435.00 | + Add to cart |
|
| R-C-1805 | 100mg | 700.00 | + Add to cart |
|
|
|
||||
Product description
Lifirafenib(BGB-283,Beigene-283)potently inhibits RAF family kinases and EGFR activities in biochemical assays with IC50 values of 23,29 and 495 nM for the recombinant BRAFV600E kinase domain,EGFR and EGFR T790M/L858R mutant.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---Lifirafenib (BGB-283) Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
